These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15101246)

  • 21. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specimen-collection standards complete major revisions.
    Ernst DJ; Szamosi DI
    MLO Med Lab Obs; 2005 Feb; 37(2):26-9. PubMed ID: 15762350
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations.
    Shafran SD; Mashinter LD; Roberts SE
    HIV Med; 2005 Nov; 6(6):421-5. PubMed ID: 16268824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of statin medications on prostate-specific antigen levels.
    Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
    J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease.
    Hsia SH; Pan D; Berookim P; Lee ML
    Am J Cardiol; 2006 Oct; 98(8):1047-52. PubMed ID: 17027569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results.
    Heintjes EM; Hirsch MW; van der Linden MW; O'Donnell JC; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2008 Aug; 24(8):2241-50. PubMed ID: 18578957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-density lipoprotein cholesterol estimation by a new formula in Indian population.
    Anandaraja S; Narang R; Godeswar R; Laksmy R; Talwar KK
    Int J Cardiol; 2005 Jun; 102(1):117-20. PubMed ID: 15939107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
    Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of honey on serum cholesterol and lipid values.
    Münstedt K; Hoffmann S; Hauenschild A; Bülte M; von Georgi R; Hackethal A
    J Med Food; 2009 Jun; 12(3):624-8. PubMed ID: 19627212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interlaboratory variability in serum lipid measurements.
    Kahn RF; McCord RS
    Fam Pract Res J; 1991 Dec; 11(4):415-20. PubMed ID: 1767687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP).
    Stevens LA; Stoycheff N
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S77-82. PubMed ID: 18359411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy.
    Konstandin MH; Blessing E; Doesch A; Ammon K; Koch A; Wabnitz GH; Gleissner CA; Remppis A; Katus HA; Dengler TJ
    Clin Transplant; 2008; 22(5):639-44. PubMed ID: 18492070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation.
    Tighe DA; Ockene IS; Reed G; Nicolosi R
    Clin Chim Acta; 2006 Mar; 365(1-2):236-42. PubMed ID: 16259972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes.
    Ferrer-García JC; Sanchez-Ballester E; Albalat-Galera R; Berzosa-Sanchez M; Herrera-Ballester A
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):183-8. PubMed ID: 18635754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of the differences in LDL-cholesterol after initiation of statin treatment.
    Caspard H; Chan AK; Walker AM
    Ann Pharmacother; 2006 Jan; 40(1):21-6. PubMed ID: 16317108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.